文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于 DNA 的分子分类器用于基因表达特征分析。

DNA-based molecular classifiers for the profiling of gene expression signatures.

机构信息

Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.

Department of Forensic Medicine, Chongqing Medical University, Chongqing, 400016, China.

出版信息

J Nanobiotechnology. 2024 Apr 17;22(1):189. doi: 10.1186/s12951-024-02445-0.


DOI:10.1186/s12951-024-02445-0
PMID:38632615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11025223/
Abstract

Although gene expression signatures offer tremendous potential in diseases diagnostic and prognostic, but massive gene expression signatures caused challenges for experimental detection and computational analysis in clinical setting. Here, we introduce a universal DNA-based molecular classifier for profiling gene expression signatures and generating immediate diagnostic outcomes. The molecular classifier begins with feature transformation, a modular and programmable strategy was used to capture relative relationships of low-concentration RNAs and convert them to general coding inputs. Then, competitive inhibition of the DNA catalytic reaction enables strict weight assignment for different inputs according to their importance, followed by summation, annihilation and reporting to accurately implement the mathematical model of the classifier. We validated the entire workflow by utilizing miRNA expression levels for the diagnosis of hepatocellular carcinoma (HCC) in clinical samples with an accuracy 85.7%. The results demonstrate the molecular classifier provides a universal solution to explore the correlation between gene expression patterns and disease diagnostics, monitoring, and prognosis, and supports personalized healthcare in primary care.

摘要

虽然基因表达特征在疾病诊断和预后方面具有巨大的潜力,但大量的基因表达特征给临床环境中的实验检测和计算分析带来了挑战。在这里,我们引入了一种通用的基于 DNA 的分子分类器,用于分析基因表达特征并生成即时的诊断结果。分子分类器从特征转换开始,使用模块化和可编程的策略来捕获低浓度 RNA 的相对关系,并将其转换为通用编码输入。然后,DNA 催化反应的竞争抑制作用根据输入的重要性为不同的输入严格分配权重,接着进行求和、消去和报告,以准确实现分类器的数学模型。我们通过利用 miRNA 表达水平在临床样本中对肝细胞癌(HCC)的诊断来验证整个工作流程,准确率为 85.7%。结果表明,分子分类器为探索基因表达模式与疾病诊断、监测和预后之间的相关性提供了一种通用的解决方案,并支持初级保健中的个性化医疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/8ec94022f77e/12951_2024_2445_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/0c793f63ef86/12951_2024_2445_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/a04cafdb35b4/12951_2024_2445_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/0953ade144a8/12951_2024_2445_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/f373d8abb405/12951_2024_2445_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/8ec94022f77e/12951_2024_2445_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/0c793f63ef86/12951_2024_2445_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/a04cafdb35b4/12951_2024_2445_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/0953ade144a8/12951_2024_2445_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/f373d8abb405/12951_2024_2445_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3544/11025223/8ec94022f77e/12951_2024_2445_Fig5_HTML.jpg

相似文献

[1]
DNA-based molecular classifiers for the profiling of gene expression signatures.

J Nanobiotechnology. 2024-4-17

[2]
Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.

EBioMedicine. 2017-4-12

[3]
Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.

Mol Oncol. 2017-12-12

[4]
A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.

Clin Chim Acta. 2017-3-30

[5]
Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.

World J Gastroenterol. 2018-8-14

[6]
A systems biology-based classifier for hepatocellular carcinoma diagnosis.

PLoS One. 2011-7-28

[7]
Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.

J Transl Med. 2019-6-18

[8]
The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.

BMC Cancer. 2018-5-18

[9]
Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.

Technol Cancer Res Treat. 2020

[10]
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.

World J Gastroenterol. 2019-1-14

引用本文的文献

[1]
Polymerase-based DNA reactions for molecularly computing cancerous diagnostic valences of multiple miRNAs.

J Nanobiotechnology. 2025-9-1

[2]
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.

Mol Cancer. 2024-9-6

本文引用的文献

[1]
Unlocking Genetic Profiles with a Programmable DNA-Powered Decoding Circuit.

Adv Sci (Weinh). 2023-7

[2]
DNA-framework-based multidimensional molecular classifiers for cancer diagnosis.

Nat Nanotechnol. 2023-6

[3]
An automated DNA computing platform for rapid etiological diagnostics.

Sci Adv. 2022-11-25

[4]
Gene expression based inference of cancer drug sensitivity.

Nat Commun. 2022-9-27

[5]
Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures.

Intensive Care Med. 2022-9

[6]
Detecting signatures of selection on gene expression.

Nat Ecol Evol. 2022-7

[7]
Logical Analysis of Multiple Single-Nucleotide-Polymorphisms with Programmable DNA Molecular Computation for Clinical Diagnostics.

Angew Chem Int Ed Engl. 2022-4-4

[8]
Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum.

Nat Commun. 2021-6-10

[9]
Tumour gene expression signature in primary melanoma predicts long-term outcomes.

Nat Commun. 2021-2-18

[10]
Cancer diagnosis with DNA molecular computation.

Nat Nanotechnol. 2020-5-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索